DK3249405T3 - Stabiliserende sammensætning for immobiliserede biomolekyler - Google Patents
Stabiliserende sammensætning for immobiliserede biomolekyler Download PDFInfo
- Publication number
- DK3249405T3 DK3249405T3 DK17176652T DK17176652T DK3249405T3 DK 3249405 T3 DK3249405 T3 DK 3249405T3 DK 17176652 T DK17176652 T DK 17176652T DK 17176652 T DK17176652 T DK 17176652T DK 3249405 T3 DK3249405 T3 DK 3249405T3
- Authority
- DK
- Denmark
- Prior art keywords
- stabilizing composition
- immobilized biomolecules
- biomolecules
- immobilized
- stabilizing
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
- G06N20/00—Machine learning
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Theoretical Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Computing Systems (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Software Systems (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Artificial Intelligence (AREA)
- Data Mining & Analysis (AREA)
- Evolutionary Computation (AREA)
- Medical Informatics (AREA)
- Computer Vision & Pattern Recognition (AREA)
- General Engineering & Computer Science (AREA)
- Mathematical Physics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09004734A EP2236520A1 (en) | 2009-03-31 | 2009-03-31 | Stabilizing composition for immobilized biomolecules |
EP10712430.7A EP2414400B1 (en) | 2009-03-31 | 2010-03-31 | Stabilizing composition for immobilized biomolecules |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3249405T3 true DK3249405T3 (da) | 2019-11-18 |
Family
ID=40946009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17176652T DK3249405T3 (da) | 2009-03-31 | 2010-03-31 | Stabiliserende sammensætning for immobiliserede biomolekyler |
Country Status (7)
Country | Link |
---|---|
US (2) | US9797895B2 (da) |
EP (3) | EP2236520A1 (da) |
JP (1) | JP5680055B2 (da) |
CN (2) | CN104031151A (da) |
DK (1) | DK3249405T3 (da) |
ES (1) | ES2757961T3 (da) |
WO (1) | WO2010115835A2 (da) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2236617A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Methods of terminal sterilization of biofunctional compositions |
JP2014522827A (ja) * | 2011-06-28 | 2014-09-08 | ロイコケア・アクチェンゲゼルシャフト | (ポリ)ペプチドのアンフォールディングを防止し、および/または(ポリ)ペプチドの(リ)フォールディングを誘導するための方法 |
EP3744833A1 (en) | 2011-06-28 | 2020-12-02 | Leukocare Ag | Stabilisation method for viruses |
US20130261153A1 (en) * | 2012-04-03 | 2013-10-03 | Boehringer Ingelheim International Gmbh | Use of ccr3-inhibitors |
US10058343B2 (en) | 2013-03-14 | 2018-08-28 | Covidien Lp | Systems for performing endoscopic procedures |
CN103446590B (zh) * | 2013-09-03 | 2015-08-26 | 珠海健帆生物科技股份有限公司 | 用于治疗扩张型心肌病的免疫吸附剂及其制备方法 |
US10588957B2 (en) | 2013-10-25 | 2020-03-17 | Leukocare Ag | Method for the production of stabile vaccines |
EP2913671A1 (en) * | 2014-02-27 | 2015-09-02 | Leukocare Ag | Novel coated carriers for the specific binding of target molecules |
JP6449221B2 (ja) * | 2016-03-24 | 2019-01-09 | 三洋化成工業株式会社 | 粒子組成物、免疫測定用試薬及び免疫測定方法 |
US20190256551A1 (en) | 2016-09-16 | 2019-08-22 | Leukocare Ag | A novel method of producing a liquid biopharmaceutical drug product |
WO2018050873A1 (en) | 2016-09-16 | 2018-03-22 | Leukocare Ag | A novel method for producing low viscous and highly concentrated biopharmaceutical drug products in liquid formulation |
KR20190053908A (ko) | 2016-09-16 | 2019-05-20 | 로이코케어 아게 | 가공 동안 바이오 의약품의 안정화를 위한 신규한 방법 |
JP7487184B2 (ja) * | 2018-05-18 | 2024-05-20 | キアゲン サイエンシーズ リミテッド ライアビリティ カンパニー | 放射線滅菌中の生物学的活性分子の防護 |
US11346764B2 (en) * | 2018-08-16 | 2022-05-31 | Essenlix Corporation | Image-based assay using intelligent monitoring structures |
CN114173831B (zh) * | 2019-05-28 | 2023-11-14 | W.L.戈尔及同仁股份有限公司 | 稳定化的医疗装置及其制造方法 |
CA3213007A1 (en) * | 2021-03-18 | 2022-09-22 | Inofea Ag | Biocatalytical composition and use for generation of immunoligand-payload conjugates |
CN114397460B (zh) * | 2021-12-09 | 2022-11-11 | 华南理工大学 | 生物标记物的保存液以及生物标记物试剂 |
WO2024043837A1 (en) * | 2022-08-26 | 2024-02-29 | Aslan Pharmaceuticals Pte Ltd | High concentration anti-il13r antibody formulation |
WO2024050817A1 (zh) * | 2022-09-09 | 2024-03-14 | 深圳华大智造科技股份有限公司 | 甘草酸或其衍生物在核酸检测中的用途 |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS597693B2 (ja) * | 1978-01-07 | 1984-02-20 | 株式会社ミドリ十字 | 抗トロンビン製剤及びその製法 |
JPS62194459A (ja) | 1986-02-21 | 1987-08-26 | Sankyo Co Ltd | 固相化試薬の安定化剤 |
AU650045B2 (en) * | 1990-09-12 | 1994-06-09 | Lifecell Corporation | Method and apparatus for cryopreparation dry stabilization and rehydration of biological suspensions |
US6309647B1 (en) * | 1999-07-15 | 2001-10-30 | Aventis Pasteur | Poxvirus—canine dispemper virus (CDV) or measles virus recombinants and compositions and methods employing the recombinants |
EP0575491B1 (en) * | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
US5863542A (en) * | 1991-03-07 | 1999-01-26 | Virogenetics Corporation | Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts |
JPH07325429A (ja) * | 1994-05-31 | 1995-12-12 | Minolta Co Ltd | 静電潜像現像用トナー |
DE19539574A1 (de) * | 1995-10-25 | 1997-04-30 | Boehringer Mannheim Gmbh | Zubereitungen und Verfahren zur Stabilisierung biologischer Materialien mittels Trocknungsverfahren ohne Einfrieren |
US20030138402A1 (en) * | 1995-12-25 | 2003-07-24 | Otsuka Pharmaceutical Co., Ltd. | Dry compositions |
JPH1099096A (ja) * | 1995-12-29 | 1998-04-21 | Ishihara Sangyo Kaisha Ltd | 生存細胞数の測定方法 |
US5730933A (en) | 1996-04-16 | 1998-03-24 | Depuy Orthopaedics, Inc. | Radiation sterilization of biologically active compounds |
US6197291B1 (en) * | 1996-06-27 | 2001-03-06 | Kanebo Limited | Agent for potentiating the effect of interleukin-8 |
US6958148B1 (en) * | 1998-01-20 | 2005-10-25 | Pericor Science, Inc. | Linkage of agents to body tissue using microparticles and transglutaminase |
CN1173744C (zh) * | 1998-05-22 | 2004-11-03 | 住友制药株式会社 | 稳定的基因制剂 |
DK1018345T3 (da) * | 1998-06-26 | 2009-03-23 | Otsuka Pharma Co Ltd | Vandoplöselige, törre sammensætninger |
US20100041023A9 (en) * | 1999-07-16 | 2010-02-18 | Herve Poulet | Inactivated FCV vaccines |
US6623861B2 (en) * | 2001-04-16 | 2003-09-23 | Battelle Memorial Institute | Multilayer plastic substrates |
WO2001044441A1 (en) * | 1999-12-14 | 2001-06-21 | Thermo Biostar, Inc. | Stabilizing diluent for polypeptides and antigens |
US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
US20030118598A1 (en) * | 2000-02-08 | 2003-06-26 | Allergan, Inc. | Clostridial toxin pharmaceutical compositions |
US20030138460A1 (en) * | 2000-02-08 | 2003-07-24 | Allergan, Inc | Methods of treating animals with botulinum toxin pharmaceutical compositions |
JP2001264332A (ja) * | 2000-03-23 | 2001-09-26 | Sanyo Chem Ind Ltd | 臨床診断用担体 |
DE10022092A1 (de) * | 2000-05-08 | 2001-11-15 | Aventis Behring Gmbh | Stabilisiertes Protein-Präparat und Verfahren zu seiner Herstellung |
AT410636B (de) * | 2001-03-23 | 2003-06-25 | Igeneon Krebs Immuntherapie | Verfahren zur herstellung eines impfstoffes |
JP2002316944A (ja) * | 2001-04-17 | 2002-10-31 | Chemo Sero Therapeut Res Inst | ヒトポリクローナル抗体組成物 |
US20030031584A1 (en) * | 2001-08-10 | 2003-02-13 | Wilson Burgess | Methods for sterilizing biological materials using dipeptide stabilizers |
US20050169886A1 (en) * | 2001-10-30 | 2005-08-04 | Brody Richard S. | Stabilization of biologically active proteins with mixtures of polysaccharides and amino acid based compounds |
WO2003072157A1 (en) * | 2002-02-21 | 2003-09-04 | Encelle, Inc. | Immobilized bioactive hydrogel matrices as surface coatings |
US20040022792A1 (en) * | 2002-06-17 | 2004-02-05 | Ralph Klinke | Method of stabilizing proteins at low pH |
US6803046B2 (en) * | 2002-08-16 | 2004-10-12 | Bracco International B.V. | Sincalide formulations |
US6770729B2 (en) * | 2002-09-30 | 2004-08-03 | Medtronic Minimed, Inc. | Polymer compositions containing bioactive agents and methods for their use |
US20050048648A1 (en) * | 2003-08-29 | 2005-03-03 | Ye Fang | Compositions & methods for reformulating biological membranes for arrays |
US20050136542A1 (en) * | 2003-12-19 | 2005-06-23 | Beckman Coulter, Inc. | Stabilized liquid reference solutions |
US20080044928A1 (en) * | 2003-12-23 | 2008-02-21 | Bharat Raghunath Char | Method for the Preparation of Ready-to-Use Support for Rapid Enzyme-Linked Immunosorbent Assay (Elisa) |
DE602004028515D1 (de) * | 2004-02-26 | 2010-09-16 | Candor Bioscience Gmbh | Wässrige lösung zur verwendung als medium für die spezifischen bindungsreaktion eines bindespaares |
ATE495760T1 (de) * | 2004-06-14 | 2011-02-15 | Ishihara Sangyo Kaisha | Gefriergetrocknete zusammensetzung aus einer inaktivierten virushülle mit membranfusionsaktivität |
AU2005257107A1 (en) * | 2004-06-24 | 2006-01-05 | Dnavec Research Inc. | Anticancer agent containing dendritic cell having RNA virus transferred thereinto |
WO2006035225A1 (en) * | 2004-09-27 | 2006-04-06 | Merz Pharma Gmbh & Co. Kgaa | Clostridial neurotoxins for use in tissue healing |
EP1656930A1 (en) * | 2004-11-10 | 2006-05-17 | Basilea Pharmaceutica AG | Stabilized freeze-dried formulation for cephalosporin derivatives |
CU23432B6 (es) * | 2005-11-02 | 2009-10-16 | Ct Ingenieria Genetica Biotech | Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras |
EP1852443A1 (en) * | 2006-05-05 | 2007-11-07 | Leukocare AG | Biocompatible three dimensional matrix for the immobilization of biological substances |
WO2008052044A2 (en) * | 2006-10-26 | 2008-05-02 | Xenoport, Inc. | Use of derivatives of propofol for treating diseases associated with oxidative stress |
EP2020601B1 (de) * | 2007-08-03 | 2010-11-17 | Micronas GmbH | Kit und Vorrichtung zum Erzeugen einer Chemolumineszenzstrahlung |
US8349367B2 (en) * | 2007-10-12 | 2013-01-08 | Bakaltcheva Irina B | Freeze-dried plasma formats for the trauma care field |
EP2058335B1 (en) * | 2007-11-07 | 2020-06-24 | Leukocare Ag | Biocompatible three dimensional matrix for the immobilization of biological substances |
US20090130756A1 (en) * | 2007-11-20 | 2009-05-21 | Pioneer Surgical Orthobiologics,Inc. | Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles |
SG187473A1 (en) * | 2008-01-15 | 2013-02-28 | Abbott Gmbh & Co Kg | Powdered protein compositions and methods of making same |
EP2236617A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Methods of terminal sterilization of biofunctional compositions |
EP3744833A1 (en) * | 2011-06-28 | 2020-12-02 | Leukocare Ag | Stabilisation method for viruses |
-
2009
- 2009-03-31 EP EP09004734A patent/EP2236520A1/en not_active Ceased
-
2010
- 2010-03-31 CN CN201410290725.9A patent/CN104031151A/zh active Pending
- 2010-03-31 CN CN201080023348.2A patent/CN102448992B/zh active Active
- 2010-03-31 WO PCT/EP2010/054391 patent/WO2010115835A2/en active Application Filing
- 2010-03-31 DK DK17176652T patent/DK3249405T3/da active
- 2010-03-31 ES ES17176652T patent/ES2757961T3/es active Active
- 2010-03-31 EP EP10712430.7A patent/EP2414400B1/en active Active
- 2010-03-31 EP EP17176652.0A patent/EP3249405B1/en active Active
- 2010-03-31 JP JP2012502685A patent/JP5680055B2/ja active Active
- 2010-03-31 US US13/262,542 patent/US9797895B2/en active Active
-
2017
- 2017-10-18 US US15/787,682 patent/US20180204137A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US9797895B2 (en) | 2017-10-24 |
EP2236520A1 (en) | 2010-10-06 |
CN102448992A (zh) | 2012-05-09 |
EP2414400B1 (en) | 2020-09-23 |
WO2010115835A3 (en) | 2010-12-02 |
JP5680055B2 (ja) | 2015-03-04 |
CN104031151A (zh) | 2014-09-10 |
ES2757961T3 (es) | 2020-04-30 |
US20120107829A1 (en) | 2012-05-03 |
EP3249405A3 (en) | 2018-02-28 |
US20180204137A1 (en) | 2018-07-19 |
EP3249405B1 (en) | 2019-08-21 |
CN102448992B (zh) | 2015-06-10 |
EP2414400A2 (en) | 2012-02-08 |
EP3249405A2 (en) | 2017-11-29 |
JP2012522236A (ja) | 2012-09-20 |
WO2010115835A2 (en) | 2010-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3249405T3 (da) | Stabiliserende sammensætning for immobiliserede biomolekyler | |
SMT201600008B (it) | Composti di piridazinone | |
SMT201600307B (it) | Composizione liposomiale | |
BR112012006859A2 (pt) | compostos | |
DK2427449T3 (da) | Vinylindazolylforbindelser | |
BRPI1013588A2 (pt) | composição | |
BRPI1013614A2 (pt) | compostos substituídos de espiro-amida | |
DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
BRPI0920707A2 (pt) | compostos | |
DK2242759T3 (da) | Forbindelser | |
BRPI1005525A2 (pt) | compostos de azaazuleno | |
UY3955Q (es) | Carrocería | |
BRPI0906749A2 (pt) | Composição | |
BRPI0913808A2 (pt) | composição | |
DK2080901T3 (da) | Vindmølle-vindmålings-kompensation | |
BRPI1015474A2 (pt) | composição | |
BRPI0917231A2 (pt) | composição | |
DK2323972T3 (da) | C7-fluor-substituerede tetracylinforbindelser | |
DK2297162T3 (da) | Forbindelser | |
BRPI1006632A2 (pt) | composição catalisadora | |
DK2310613T3 (da) | Forbedret brudled til stigrør | |
BRPI0909633A2 (pt) | anticorpos anti-tyrp1 | |
BRPI0918344A2 (pt) | composição catalítica | |
BRPI0916432A2 (pt) | compostos | |
BRPI1005290A2 (pt) | composição |